Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 22,205 |
|
|||||
| News | - | ||||||
| Day High | 1.03 | Low High |
|||||
| Day Low | 1.01 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ainos Inc | AIMD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.01 | -0.97% | 1.02 | 18:41:28 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.0202 | 1.01 | 1.03 | 1.03 | 1.03 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 99 | 22,205 | $ 1.02 | $ 22,572 | - | 0.79 - 6.097 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:33:27 | 13 | $ 1.02 | USD |
Ainos Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.07M | 5.95M | - | 122k | -13.77M | -2.31 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ainos News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AIMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.03 | 1.0799 | 1.01 | 1.04 | 22,544 | -0.01 | -0.97% |
| 1 Month | 1.27 | 1.33 | 1.00 | 1.16 | 83,250 | -0.25 | -19.69% |
| 3 Months | 0.9613 | 3.10 | 0.79 | 1.78 | 1,491,482 | 0.0587 | 6.11% |
| 6 Months | 3.10 | 4.2899 | 0.79 | 2.04 | 970,242 | -2.08 | -67.10% |
| 1 Year | 4.50 | 6.097 | 0.79 | 2.39 | 548,583 | -3.48 | -77.33% |
| 3 Years | 18.60 | 18.75 | 0.79 | 4.66 | 561,432 | -17.58 | -94.52% |
| 5 Years | 18.60 | 18.75 | 0.79 | 4.66 | 561,432 | -17.58 | -94.52% |
Ainos Description
| Ainos is a diversified healthcare company focused on the development of novel point-of-care testing (POCT), low-dose VELDONA interferon therapeutics, and synthetic RNA-driven preventative medicine. The company¿s products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. |
